3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
11
Nasopharyngeal Carcinoma
6
Oropharyngeal Neoplasms
5
Prostatic Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma
4
Mouth Neoplasms
3
Hypopharyngeal Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mesothelioma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Anus Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Mesothelioma, Malignant
1
Meningioma
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced Cervical Adenocarcinoma
1
HIV Infections
1
Glioma
1
Glioblastoma
1
Interventions
Letrozole
27
Fulvestrant
27
Specimen Handling
24
ribociclib
17
pembrolizumab
16
exemestane
16
Paclitaxel
16
Carboplatin
16
Capecitabine
16
Anastrozole
16
Magnetic Resonance Spectroscopy
15
palbociclib
14
Tamoxifen
13
trastuzumab deruxtecan
12
Trastuzumab
12
Biopsy
11
abemaciclib
10
Cyclophosphamide
10
pertuzumab
8
Radiotherapy
8
elacestrant
7
sacituzumab govitecan
6
patritumab deruxtecan
6
olaparib
6
inavolisib
6
giredestrant
6
Surveys and Questionnaires
6
Radiation
6
eribulin
5
Standard of Care
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.